• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday

    4/22/24 10:10:39 AM ET
    $ANL
    $COIN
    $CRML
    $CSGP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance: Consumer Services
    Finance
    Get the next $ANL alert in real time by email

    U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Monday.

    Shares of Matterport, Inc. (NASDAQ:MTTR) rose sharply during Monday's session.

    CoStar Group, Inc. (NASDAQ:CSGP) announced plans to acquire Matterport in a cash and stock transaction valued at $5.50 per share reflecting an estimated $1.6 billion value.

    Matterport shares climbed 184% to $4.93 on Monday.

    Here are some other big stocks recording gains in today's session.

    • Graphjet Technology (NASDAQ:GTI) surged 27.6% to $8.61. Graphjet Technology’s Tham Choi Kuen, CFO, announced the decision to resign due to health reasons, effective immediately.
    • Adlai Nortye Ltd. (NASDAQ:ANL) gained 12.1% to $13.90.
    • MicroStrategy Incorporated (NASDAQ:MSTR) shares climbed 11.2% to $1,305.56 amid a rise in Bitcoin.
    • Sea Limited (NYSE:SE) surged 10.4% to $60.79 after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $62 to $70.
    • Ingevity Corporation (NYSE:NGVT) climbed 8.7% to $48.30. Jefferies analyst Daniel Rizzo upgraded Ingevity from Hold to Buy and raised the price target from $52 to $62.
    • KB Financial Group Inc. (NYSE:KB) surged 8.2% to $50.01.
    • Riot Platforms, Inc. (NASDAQ:RIOT) gained 7.9% to $9.85 amid a rise in Bitcoin.
    • Guardant Health, Inc. (NASDAQ:GH) climbed 7.9% to $17.31. The Molecular and Clinical Genetics Panel of the U.S. FDA Medical Devices Advisory Committee is scheduled to review the premarket approval application for the company’s Shield™ blood test for colorectal cancer (CRC) screening on May 23, 2024.
    • Lexeo Therapeutics, Inc. (NASDAQ:LXEO) rose 6.7% to $12.86 as the company announced a license agreement to accelerate development of LX2006 for the treatment of friedreich ataxia cardiomyopathy.
    • Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) gained 6.5% to $1.7550
    • Coinbase Global, Inc. (NASDAQ:COIN) shares rose 6.5% to $224.72 amid a rise in Bitcoin.
    • Critical Metals Corp. (NASDAQ:CRML) gained 6.2% to $8.60.
    • Fresenius Medical Care AG (NYSE:FMS) rose 5.4% to $20.60.

    Read More: Wall Street’s Most Accurate Analysts’ Views On 3 Defensive Stocks Delivering High-Dividend Yields

    Get the next $ANL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ANL
    $COIN
    $CRML
    $CSGP

    CompanyDatePrice TargetRatingAnalyst
    Strategy Inc
    $MSTR
    3/10/2026$175.00Buy
    B. Riley Securities
    CoStar Group Inc.
    $CSGP
    2/20/2026$67.00Hold → Buy
    Jefferies
    Guardant Health Inc.
    $GH
    2/20/2026$125.00 → $135.00Buy
    Canaccord Genuity
    Guardant Health Inc.
    $GH
    2/17/2026$120.00Outperform
    Robert W. Baird
    Adlai Nortye Ltd.
    $ANL
    2/13/2026$16.00Neutral → Buy
    H.C. Wainwright
    Coinbase Global Inc.
    $COIN
    2/12/2026$120.00Buy → Neutral
    Monness Crespi & Hardt
    Coinbase Global Inc.
    $COIN
    1/28/2026$240.00Neutral
    Robert W. Baird
    Strategy Inc
    $MSTR
    1/27/2026$213.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $ANL
    $COIN
    $CRML
    $CSGP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Sage Antony William Paul

    3 - Critical Metals Corp. (0001951089) (Issuer)

    3/18/26 7:54:42 PM ET
    $CRML
    Metal Mining
    Basic Materials

    SEC Form 3 filed by new insider Thomas John Harper

    3 - Critical Metals Corp. (0001951089) (Issuer)

    3/18/26 7:48:13 PM ET
    $CRML
    Metal Mining
    Basic Materials

    SEC Form 3 filed by new insider Mcnamara Thomas M.

    3 - Critical Metals Corp. (0001951089) (Issuer)

    3/18/26 7:43:40 PM ET
    $CRML
    Metal Mining
    Basic Materials

    $ANL
    $COIN
    $CRML
    $CSGP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities initiated coverage on Strategy Inc with a new price target

    B. Riley Securities initiated coverage of Strategy Inc with a rating of Buy and set a new price target of $175.00

    3/10/26 8:42:16 AM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    CoStar Group upgraded by Jefferies with a new price target

    Jefferies upgraded CoStar Group from Hold to Buy and set a new price target of $67.00

    2/20/26 8:19:35 AM ET
    $CSGP
    Real Estate

    Canaccord Genuity reiterated coverage on Guardant Health with a new price target

    Canaccord Genuity reiterated coverage of Guardant Health with a rating of Buy and set a new price target of $135.00 from $125.00 previously

    2/20/26 8:00:16 AM ET
    $GH
    Medical Specialities
    Health Care

    $ANL
    $COIN
    $CRML
    $CSGP
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    July 30, 2024 - FDA Roundup: July 30, 2024

    For Immediate Release: July 30, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA is announcing the fiscal year (FY) 2025 user fee rates for importers approved to participate in the Voluntary Qualified Importer Program (VQIP) and accreditation and certification bodies interested in participating in the Accredited Third-Party C

    7/30/24 3:38:18 PM ET
    $GH
    Medical Specialities
    Health Care

    FDA Approval for INPEFA issued to LEXICON PHARMACEUTICALS INC

    Submission status for LEXICON PHARMACEUTICALS INC's drug INPEFA (ORIG-1) with active ingredient SOTAGLIFLOZIN has changed to 'Approval' on 05/26/2023. Application Category: NDA, Application Number: 216203, Application Classification: Type 1 - New Molecular Entity

    5/30/23 10:02:49 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    May 28, 2021 - FDA Approves First Targeted Therapy for Lung Cancer Mutation Previously Considered Resistant to Drug Therapy

    For Immediate Release: May 28, 2021 Today, the U.S. Food and Drug Administration approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C and who have received at least one prior systemic therapy. This is the first approved targeted therapy for tumors with any KRAS mutation, which accounts for ap

    5/28/21 1:05:48 PM ET
    $AMGN
    $GH
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Medical Specialities

    $ANL
    $COIN
    $CRML
    $CSGP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Sams Louise S bought $48,360 worth of shares (1,000 units at $48.36), increasing direct ownership by 5% to 20,409 units (SEC Form 4)

    4 - COSTAR GROUP, INC. (0001057352) (Issuer)

    3/9/26 8:00:08 AM ET
    $CSGP
    Real Estate

    Director Glaser Rachel C bought $44,940 worth of shares (1,000 units at $44.94), increasing direct ownership by 32% to 4,157 units (SEC Form 4)

    4 - COSTAR GROUP, INC. (0001057352) (Issuer)

    3/3/26 4:09:37 PM ET
    $CSGP
    Real Estate

    President, Marketplaces Saint Frederick G. covered exercise/tax liability with 11,096 shares and bought $906,600 worth of shares (20,000 units at $45.33), increasing direct ownership by 3% to 279,851 units (SEC Form 4)

    4 - COSTAR GROUP, INC. (0001057352) (Issuer)

    3/3/26 4:09:07 PM ET
    $CSGP
    Real Estate

    $ANL
    $COIN
    $CRML
    $CSGP
    SEC Filings

    View All

    SEC Form F-3 filed by Critical Metals Corp.

    F-3 - Critical Metals Corp. (0001951089) (Filer)

    3/18/26 4:15:36 PM ET
    $CRML
    Metal Mining
    Basic Materials

    SEC Form DEFA14A filed by Ingevity Corporation

    DEFA14A - Ingevity Corp (0001653477) (Filer)

    3/17/26 4:26:43 PM ET
    $NGVT
    Major Chemicals
    Industrials

    SEC Form DEF 14A filed by Ingevity Corporation

    DEF 14A - Ingevity Corp (0001653477) (Filer)

    3/17/26 4:25:30 PM ET
    $NGVT
    Major Chemicals
    Industrials

    $ANL
    $COIN
    $CRML
    $CSGP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Homes.com Expands Early Access to Pre-Market Listings

    eXp Realty becomes the first national brokerage to participate in Homes.com's new pre-marketing display program Homes.com, a CoStar Group (NASDAQ:CSGP) online residential marketplace, today announced plans to expand consumer access to pre-market listings, giving homebuyers an early look at homes before they are officially listed for sale. eXp Realty®, the core subsidiary of eXp World Holdings, Inc. (NASDAQ:EXPI) will be the first national brokerage to participate in Homes.com's new pre-marketing display program. The initiative reflects Homes.com's commitment to consumer transparency and seller choice. Pre-market listings will appear on Homes.com only when a listing agent opts in under s

    3/18/26 9:00:00 AM ET
    $CSGP
    $EXPI
    Real Estate
    Finance

    Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026

    Guardant Reveal demonstrates expanded utility in identifying new, primary cancers during minimal residual disease (MRD) monitoring Studies show strong performance of Guardant360 Tissue in determining tissue of origin in diagnostically challenging settings Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced the company and its research collaborators will present 28 abstracts, including 3 oral sessions, showcasing advances in methylation-based tumor classification and liquid biopsy technology at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, California taking place April 17 - 22, 2026. Key data that will be presen

    3/18/26 8:05:00 AM ET
    $GH
    Medical Specialities
    Health Care

    Homes.com Shares Most Expensive Home Sales Across Major U.S. Markets in February

    $52.5 million home in New York City inks the most expensive sale of the month as multiple markets recorded transactions above $20 million Homes.com, a CoStar Group (NASDAQ:CSGP) leading online residential marketplace, published the most expensive publicly marketed home sales across major U.S. metropolitan areas for the month of February. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260317390108/en/A look at the nation's priciest publicly marketed home sales The list highlights the top closed sales in leading markets nationwide based on publicly marketed transactions recorded in multiple listing service (MLS) data. February's

    3/17/26 9:00:00 AM ET
    $CSGP
    Real Estate

    $ANL
    $COIN
    $CRML
    $CSGP
    Leadership Updates

    Live Leadership Updates

    View All

    Critical Metals Corp Appoints Chang Oh Turkmani to Its Advisory Board

    NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Critical Metals Corp. (NASDAQ:CRML) ("Critical Metals Corp" or the "Company"), a leading critical minerals mining company, today announced the appointment of Chang Oh Turkmani, a multi-lingual international trade attorney, business executive, and energy and infrastructure investor, to its Advisory Board. Turkmani is a highly accomplished legal and business leader with more than three decades of experience in international trade, cross-border negotiation, and global commodity markets. She is the Managing Director and Principal of The Mega Company, a Washington, D.C.–based private development and investment firm she founded in 1983. Through the f

    3/16/26 8:30:00 AM ET
    $CRML
    Metal Mining
    Basic Materials

    CoStar Group Appoints Nana Banerjee to Its Board of Directors

    Appointment Brings Additional Experience in AI and Advanced Analytics to the Board as the Company Advances its Long-Term Growth Strategy CoStar Group, Inc. (NASDAQ:CSGP), a leading provider of online real estate marketplaces, information, analytics, and 3D digital twin technology in the property markets, today announced that Nana Banerjee has been appointed as a new independent member of the Company's Board of Directors (the "Board"), effective immediately. With this appointment, the Board expands to nine directors, eight of whom are independent. Nana Banerjee brings more than two decades of experience leading and scaling global technology and data-driven businesses to the Board. Most r

    3/16/26 4:00:00 AM ET
    $CSGP
    Real Estate

    The D. E. Shaw Group Releases Open Letter and Presentation to the Board of Directors of CoStar Group

    Expresses Disappointment with the Board's Failure to Address the Company's Value Destructive Capital Spending and Longstanding Underperformance Reiterates the Need for Improved Capital Allocation and Enhanced Board Oversight Announces Intention to Support Shareholder-Driven Change at the 2026 Annual Meeting NEW YORK, Feb. 4, 2026 /PRNewswire/ -- The D. E. Shaw group, a global investment and technology development firm with more than $85 billion in investment capital and a history of working with companies to help build long-term value, today sent an open letter and presentation to the Board of Directors of CoStar Group, Inc. (NASDAQ:CSGP) ("CoStar" or the "Company") expressing continued disa

    2/4/26 9:00:00 AM ET
    $CSGP
    Real Estate

    $ANL
    $COIN
    $CRML
    $CSGP
    Financials

    Live finance-specific insights

    View All

    Strive Adds $50M of STRC to its Corporate Treasury

    Strategy Inc (NASDAQ:STRF, LuxSE: STRE)) ("Strategy") today announced that Strive, Inc. ("Strive") has allocated $50 million, representing over one-third of its corporate treasury, to STRC (Strategy's Variable Rate Series A Perpetual Stretch Preferred Stock). "We are encouraged to see innovative institutions continue integrating STRC into their treasury strategies," said Phong Le, Chief Executive Officer of Strategy. "Prevalon Energy, Anchorage Digital, and OranjeBTC have already added STRC to their corporate treasuries, and Strive is now the latest corporation to publicly announce doing so. Adoption continues to grow as more institutions recognize the role Digital Credit can play in mode

    3/11/26 9:00:00 AM ET
    $ASST
    $MSTR
    $STRC
    Computer Software: Prepackaged Software
    Technology
    Wholesale Distributors
    Industrials

    Lexicon Pharmaceuticals Reports Fourth Quarter 2025 Financial Results and Provides Clinical Updates

    Pivotal sotagliflozin milestones on schedule including resubmission of NDA in T1D and enrollment of SONATA study for HCM  Positive End-of-Phase 2 meeting with FDA for pilavapadin confirms Phase 3 readiness and supports ongoing partnership discussions Strengthened financial position with more than $100 million in additional cash from capital raise and Novo Nordisk milestone payment Conference call and webcast at 8:30 am ET   THE WOODLANDS, Texas, March 05, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), today reported financial results for the three months and year ended December 31, 2025, and provided an update on key corporate milestones and accomplishments.  "

    3/5/26 6:59:00 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sea Limited Reports Fourth Quarter and Full Year 2025 Results

    Sea Limited (NYSE:SE) ("Sea" or the "Company") today announced its financial results for the fourth quarter and full year ended December 31, 2025. In the fourth quarter of 2025, Sea's GAAP revenue was US$6.9 billion, up 38.4% year-on-year. The Company also achieved gross profit of US$3.0 billion, up 36.0% year-on-year, and net income of US$410.9 million, up 72.9% year-on-year. Adjusted EBITDA1 increased by 33.2% year-on-year to reach US$787.1 million. For the full year of 2025, Sea's GAAP revenue was US$22.9 billion, up 36.4% year-on-year, with gross profit growing 42.2% year-on-year to US$10.2 billion. Net income reached US$1.6 billion, as compared to net income of US$447.8 million for

    3/3/26 6:30:00 AM ET
    $SE
    Other Consumer Services
    Consumer Discretionary

    $ANL
    $COIN
    $CRML
    $CSGP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Critical Metals Corp.

    SC 13D/A - Critical Metals Corp. (0001951089) (Subject)

    12/13/24 4:10:59 PM ET
    $CRML
    Metal Mining
    Basic Materials

    Amendment: SEC Form SC 13D/A filed by Lexicon Pharmaceuticals Inc.

    SC 13D/A - LEXICON PHARMACEUTICALS, INC. (0001062822) (Subject)

    12/9/24 9:33:20 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by MicroStrategy Incorporated

    SC 13G - MICROSTRATEGY Inc (0001050446) (Subject)

    11/14/24 6:24:12 PM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology